Detalles de la búsqueda
1.
Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 trial.
Clin Auton Res
; 31(6): 699-711, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34657222
2.
Efficacy of revefenacin, a long-acting muscarinic antagonist for nebulized therapy, in patients with markers of more severe COPD: a post hoc subgroup analysis.
BMC Pulm Med
; 20(1): 134, 2020 May 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32393215
3.
Maintained therapeutic effect of revefenacin over 52 weeks in moderate to very severe Chronic Obstructive Pulmonary Disease (COPD).
Respir Res
; 20(1): 241, 2019 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31666076
4.
Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized, double-blind, phase 2 studies.
Pulm Pharmacol Ther
; 48: 71-79, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28987804
5.
A 28-day, randomized, double-blind, placebo-controlled, parallel group study of nebulized revefenacin in patients with chronic obstructive pulmonary disease.
Respir Res
; 18(1): 182, 2017 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29096627
6.
A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19.
Eur Respir J
; 58(4)2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34210790
7.
The Study to Understand Mortality and Morbidity in COPD (SUMMIT) study protocol.
Eur Respir J
; 41(5): 1017-22, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23018908
8.
Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trial.
BMJ Open Respir Res
; 10(1)2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37460276
9.
Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial.
Thorax
; 67(1): 35-41, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21828231
10.
24-h duration of the novel LABA vilanterol trifenatate in asthma patients treated with inhaled corticosteroids.
Eur Respir J
; 40(3): 570-9, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22362859
11.
Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids.
Ann Allergy Asthma Immunol
; 109(5): 353-358.e4, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23062392
12.
Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial.
Respir Res
; 12: 132, 2011 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-21977941
13.
Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma.
Respir Res
; 12: 160, 2011 Dec 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-22188590
14.
Data on the safety and tolerability of revefenacin, in patients with moderate to very severe chronic obstructive pulmonary disease.
Data Brief
; 26: 104277, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31534988
15.
Improvements in Lung Function with Nebulized Revefenacin in the Treatment of Patients with Moderate to Very Severe COPD: Results from Two Replicate Phase III Clinical Trials.
Chronic Obstr Pulm Dis
; 6(2): 154-165, 2019 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30974049
16.
Revefenacin, a once-daily, lung-selective, long-acting muscarinic antagonist for nebulized therapy: Safety and tolerability results of a 52-week phase 3 trial in moderate to very severe chronic obstructive pulmonary disease.
Respir Med
; 153: 38-43, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31150963
17.
Efficacy and optimal dosing interval of the long-acting beta2 agonist, vilanterol, in persistent asthma: a randomised trial.
Respir Med
; 106(8): 1110-5, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22520084
18.
The efficacy and safety of the novel long-acting ß2 agonist vilanterol in patients with COPD: a randomized placebo-controlled trial.
Chest
; 142(1): 119-127, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22241764
19.
Dose effect of once-daily fluticasone furoate in persistent asthma: a randomized trial.
Respir Med
; 106(5): 642-50, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22342538
20.
Evaluation of an ambulatory system for the quantification of cough frequency in patients with chronic obstructive pulmonary disease.
Cough
; 1: 3, 2005 Aug 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-16270923
Resultados
1 -
20
de 20
1
Próxima >
>>